Market Summary
USD32.25-0.43
Market Closed-1.32%
PRGO Alerts
PRGO Stock Price
PRGO RSI Chart
PRGO Valuation
PRGO Price/Sales (Trailing)
PRGO Profitability
PRGO Fundamentals
PRGO Revenue
PRGO Earnings
Price Action
52 Week Range
30.7841.15
(Low)(High)
Last 7 days
-3.8%
Last 30 days
-14.9%
Last 90 days
-3.8%
Trailing 12 Months
-16.5%
PRGO Financial Health
PRGO Investor Care
Historical Charts for Stock Metrics
Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
Get all data in R, Python etc through our Historical Stock Data APIs
Latest Insider Trading transactions for PRGO
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
2023-08-15 | Manzone Albert | sold (taxes) | -102,254 | 38.88 | -2,630 | - |
2023-08-15 | Manzone Albert | acquired | 212,985 | 38.88 | 5,478 | - |
2023-07-07 | HANSON KYLE | sold (taxes) | -118,871 | 32.63 | -3,643 | evp & general counsel |
2023-07-07 | HANSON KYLE | acquired | 404,906 | 32.63 | 12,409 | evp & general counsel |
2023-07-07 | Ives Alison | sold (taxes) | -8,842 | 32.63 | -271 | evp & chief scientific officer |
2023-07-07 | Ives Alison | acquired | 30,019 | 32.63 | 920 | evp & chief scientific officer |
2023-06-13 | Parker Geoffrey M. | bought | 330,637 | 33.0637 | 10,000 | - |
2023-06-07 | Bezerra Eduardo Guarita | acquired | 152,819 | 33.72 | 4,532 | evp & chief financial officer |
2023-06-07 | Bezerra Eduardo Guarita | sold (taxes) | -37,226 | 33.72 | -1,104 | evp & chief financial officer |
2023-05-23 | Andersen Svend | bought | 96,902 | 33.4146 | 2,900 | evp & president chci |
Which funds bought or sold PRGO recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
2023-09-21 | Jefferies Group LLC | new | - | 138,753 | 138,753 | -% |
2023-09-20 | BARCLAYS PLC | added | 147 | 2,088,000 | 3,640,000 | -% |
2023-09-12 | Farther Finance Advisors, LLC | sold off | -100 | -1,291 | - | -% |
2023-08-25 | Gould Capital, LLC | unchanged | - | -13.00 | 238 | -% |
2023-08-23 | Stonebridge Capital Advisors LLC | unchanged | - | -19.00 | 340 | -% |
2023-08-23 | Dean Capital Management | reduced | -21.14 | -155,730 | 458,257 | 0.61% |
2023-08-22 | Asset Dedication, LLC | unchanged | - | -1,000 | 5,000 | -% |
2023-08-21 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | added | 10.3 | 34,000 | 807,000 | 0.01% |
2023-08-21 | OSAIC HOLDINGS, INC. | reduced | -18.64 | -526,340 | 1,761,360 | -% |
2023-08-21 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -2.52 | -471,987 | 5,625,450 | 0.01% |
Latest Funds Activity
Calls
Puts
Net Call Options
No. of Funds
PRGO Alerts
Schedule 13G FIlings of Perrigo Company
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| Feb 15, 2023 | barrow hanley mewhinney & strauss llc | 7.30% | 9,825,539 | SC 13G | |
| Feb 14, 2023 | price t rowe associates inc /md/ | 0.1% | 78,305 | SC 13G/A | |
| Feb 14, 2023 | price t rowe associates inc /md/ | 0.1% | 78,305 | SC 13G/A | |
| Feb 09, 2023 | vanguard group inc | 10.84% | 14,590,276 | SC 13G/A | |
| Jan 24, 2023 | blackrock inc. | 9.8% | 13,221,594 | SC 13G/A | |
| Feb 14, 2022 | price t rowe associates inc /md/ | 8.0% | 10,721,574 | SC 13G/A | |
| Feb 03, 2022 | blackrock inc. | 8.6% | 11,557,239 | SC 13G/A | |
| Jan 10, 2022 | barrow hanley mewhinney & strauss llc | 10.10% | 13,505,133 | SC 13G | |
| Nov 10, 2021 | price t rowe associates inc /md/ | 8.4% | 11,328,393 | SC 13G/A | |
| Sep 10, 2021 | price t rowe associates inc /md/ | 18.0% | 24,135,892 | SC 13G/A |
Recent SEC filings of Perrigo Company
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| Sep 20, 2023 | 3 | Insider Trading | |
| Sep 11, 2023 | 8-K | Current Report | |
| Aug 17, 2023 | 4 | Insider Trading | |
| Aug 09, 2023 | 8-K | Current Report | |
| Aug 08, 2023 | 8-K | Current Report | |
| Aug 08, 2023 | 10-Q | Quarterly Report | |
| Jul 12, 2023 | 4 | Insider Trading | |
| Jul 10, 2023 | 4 | Insider Trading | |
| Jul 10, 2023 | 4 | Insider Trading | |
| Jul 07, 2023 | 3 | Insider Trading |
Peers (Alternatives to Perrigo Company)
View All Peers In Detail| Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|
| LARGE-CAP | ||||||||
LLY | 495.3B | 29.5B | -0.51% | 77.59% | 76.23 | 16.78 | 1.53% | 14.16% |
JNJ | 417.0B | 97.8B | -1.74% | -2.10% | 31.95 | 4.27 | 2.29% | -28.92% |
MRK | 272.8B | 58.3B | -4.46% | 23.17% | 17.88 | 4.63 | 2.00% | -81.24% |
PFE | 184.6B | 77.9B | -10.83% | -26.03% | 8.6 | 2.37 | -23.04% | -26.74% |
BMY | 150.1B | 45.2B | -4.32% | -16.75% | 23.72 | 3.25 | -4.15% | 20.34% |
| MID-CAP | ||||||||
RETA | 6.5B | - | 1.87% | 616.21% | -74.09 | 4.1K | -86.94% | 71.24% |
PRGO | 4.4B | 4.6B | -14.86% | -16.47% | -64.45 | 0.94 | 6.60% | 42.04% |
| SMALL-CAP | ||||||||
TLRY | 1.6B | 627.1M | -7.75% | -14.29% | -1.08 | 2.51 | -0.20% | -204.67% |
SUPN | 1.5B | 634.0M | -12.24% | -14.48% | 35.26 | 2.41 | 0.62% | -24.59% |
INVA | 841.4M | 244.3M | -2.86% | 8.68% | 4.27 | 3.44 | -39.50% | -4.99% |
CRON | 792.7M | 109.5M | 17.51% | -27.27% | -5.52 | 7.24 | -2.66% | -32.13% |
ACRS | 470.6M | 31.2M | -8.53% | -51.99% | -4.47 | 15.1 | 407.54% | -26.47% |
CGC | 462.3M | 453.3M | 100.98% | -69.12% | -0.38 | 1.02 | -16.04% | 55.90% |
OCUL | 252.8M | 54.6M | -17.14% | -44.23% | -2.79 | 4.63 | 9.39% | -179.16% |
ENDP | - | 2.2B | - | - | - | - | -22.39% | 63.59% |
Perrigo Company News
Returns for PRGO
Cumulative Returns on PRGO
-11.7%
10-Year Cumulative Returns
-13.5%
7-Year Cumulative Returns
-13.9%
5-Year Cumulative Returns
-10.3%
3-Year Cumulative Returns
Risks for PRGO
What is the probability of a big loss on PRGO?
89.6%
Probability that Perrigo Company stock will be more than 20% underwater in next one year
37.7%
Probability that Perrigo Company stock will be more than 30% underwater in next one year.
18.9%
Probability that Perrigo Company stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.
How does PRGO drawdown profile look like?
Y-axis is the maximum loss one would have experienced if Perrigo Company was unfortunately bought at previous high price.
Drawdowns
Financials for Perrigo Company
Income Statement (Last 12 Months)(In Millions)
| Income Statement (Last 12 Months) | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Revenue | 1.6% | 4,630 | 4,559 | 4,452 | 4,401 | 4,344 | 4,203 | 4,139 | 4,323 | 4,284 | 4,251 | 4,325 | 4,358 | 4,546 | 4,746 | 4,837 | 4,710 | 4,652 | 4,689 | 4,732 | 4,820 | 4,918 |
| Gross Profit | 3.7% | 1,587 | 1,531 | 1,455 | 1,435 | 1,409 | 1,386 | 1,416 | 1,523 | 1,556 | 1,555 | 1,580 | 1,592 | 1,635 | 1,718 | 1,773 | 1,735 | 1,747 | 1,788 | 1,832 | 1,901 | 1,974 |
| Operating Expenses | -0.5% | 1,418 | 1,426 | 1,377 | 1,341 | 909 | 1,005 | 1,006 | 1,037 | 1,430 | 1,240 | 1,230 | 1,061 | 1,128 | 1,220 | 1,259 | 1,416 | 1,605 | 1,605 | 1,595 | 1,614 | 1,402 |
| S&GA Expenses | 3.3% | 637 | 617 | 585 | 562 | 548 | 537 | 536 | 562 | 562 | 541 | 546 | 505 | 509 | 530 | 539 | 567 | 568 | 583 | 596 | 596 | 604 |
| R&D Expenses | 0.6% | 126 | 125 | 123 | 121 | 119 | 120 | 122 | 125 | 128 | 125 | 122 | 80.00 | 94.00 | 107 | 119 | 173 | 172 | 220 | 219 | 221 | 216 |
| EBITDA | - | - | - | - | - | - | - | - | 501 | 522 | 541 | 544 | 551 | 559 | 560 | 565 | 561 | 564 | 576 | 586 | - | - |
| EBITDA Margin | - | - | - | - | - | - | - | - | 0.12* | 0.12* | 0.11* | 0.11* | 0.11* | 0.11* | 0.11* | 0.12* | 0.12* | 0.12* | 0.12* | 0.12* | - | - |
| Interest Expenses | -3.5% | -169 | -163 | -156 | -145 | -135 | -128 | -125 | -127 | -130 | -130 | -127 | -121 | -118 | -117 | -117 | -123 | -124 | -125 | -128 | -130 | -133 |
| Earnings Before Taxes | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 291 | - | - |
| EBT Margin | - | - | - | - | - | - | - | - | 0.07* | 0.06* | 0.06* | 0.06* | 0.06* | 0.06* | 0.06* | 0.06* | 0.06* | 0.06* | 0.06* | 0.06* | - | - |
| Net Income | 52.1% | -67.70 | -141 | -140 | -107 | -116 | -109 | -68.90 | -253 | -349 | -230 | -162 | -6.60 | 240 | 189 | 146 | 247 | 87.00 | 114 | 131 | 123 | 235 |
| Net Income Margin | 100.0% | - | -0.03* | -0.03* | -0.02* | -0.03* | -0.03* | -0.02* | -0.06* | -0.08* | -0.05* | -0.03* | 0.00* | 0.05* | 0.04* | 0.03* | - | - | - | - | - | - |
| Free Cashflow | -100.0% | - | 148 | 211 | -95.70 | 168 | 108 | 4.00 | 196 | -87.30 | 283 | 466 | 464 | 549 | 315 | 250 | - | - | - | - | - | - |
Balance Sheet(In Millions)
| Balance Sheet | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Assets | 0.1% | 10,965 | 10,955 | 11,017 | 10,678 | 10,920 | 10,390 | 10,426 | 10,916 | 11,230 | 11,325 | 11,488 | 11,576 | 12,128 | 11,401 | 11,301 | 11,311 | 11,429 | 11,120 | 10,983 | 10,943 | 11,226 |
| Current Assets | 1.2% | 2,773 | 2,741 | 2,720 | 2,583 | 2,652 | 3,936 | 3,860 | 4,226 | 4,420 | 4,489 | 3,134 | 3,398 | 3,804 | 3,046 | 2,731 | 2,740 | 3,435 | 3,009 | 2,902 | 2,769 | 2,779 |
| Cash Equivalents | 0.4% | 555 | 553 | 601 | 469 | 485 | 1,966 | 1,865 | 2,078 | 318 | 471 | 632 | 840 | 1,438 | 492 | 345 | 399 | 1,056 | 838 | 542 | 444 | 527 |
| Inventory | -1.3% | 1,168 | 1,183 | 1,150 | 1,085 | 1,080 | 1,022 | 1,020 | 1,093 | 1,116 | 1,136 | 1,059 | 1,101 | 1,035 | 931 | 967 | 991 | 941 | 913 | 878 | 885 | 884 |
| Net PPE | -0.1% | 918 | 919 | 926 | 840 | 840 | 846 | 864 | 843 | 834 | 860 | 865 | 919 | 892 | 889 | 774 | 871 | 824 | 821 | 829 | 820 | 812 |
| Liabilities | -0.1% | 6,116 | 6,121 | 6,175 | 6,075 | 6,070 | 5,285 | 5,274 | 5,734 | 5,719 | 5,767 | 5,833 | 5,756 | 6,217 | 5,614 | 5,497 | 5,552 | 5,702 | 5,419 | 5,315 | 5,283 | 5,328 |
| Current Liabilities | -2.8% | 1,057 | 1,087 | 1,114 | 1,015 | 1,015 | 981 | 1,588 | 2,004 | 1,985 | 1,447 | 1,382 | 1,336 | 1,860 | 1,635 | 1,336 | 1,325 | 1,791 | 1,832 | 1,537 | 1,494 | 1,538 |
| LT Debt, Current | -1.0% | 38.00 | 39.00 | 36.00 | 34.00 | 31.00 | 5.00 | 604 | 629 | 630 | 36.00 | 37.00 | 17.00 | 607 | 288 | 3.00 | 3.00 | 399 | 468 | 190 | 194 | 198 |
| LT Debt, Non Current | -0.2% | 4,056 | 4,063 | 4,070 | 4,078 | 4,086 | 3,511 | 2,917 | 2,921 | 2,926 | 3,525 | 3,528 | 3,544 | 3,536 | 3,183 | 3,366 | 3,362 | 3,084 | 2,750 | 3,052 | 3,071 | 3,085 |
| Shareholder's Equity | 0.3% | 4,849 | 4,834 | 4,842 | 4,603 | 4,850 | 5,105 | 5,152 | 5,182 | 5,511 | 5,558 | 5,655 | 5,820 | 5,910 | 5,786 | 5,804 | 5,759 | 5,726 | 5,701 | 5,668 | 5,660 | 5,897 |
| Retained Earnings | 0.4% | -2,062 | -2,070 | -2,067 | -2,043 | -1,994 | -1,929 | -1,927 | -1,936 | -1,877 | -1,820 | -1,858 | -1,683 | -1,528 | -1,589 | -1,695 | -1,676 | -1,768 | -1,777 | -1,838 | -1,919 | -1,852 |
| Shares Outstanding | 0.3% | 135 | 135 | - | 135 | 135 | 134 | - | 134 | 134 | 133 | 135 | 137 | 136 | 136 | 136 | 136 | 136 | 136 | 136 | 137 | 138 |
| Minority Interest | - | - | - | - | - | - | - | - | - | - | - | - | 0.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cashflow (Last 12 Months)(In Millions)
| Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Cashflow From Operations | 28.2% | 317 | 248 | 307 | 16.00 | 301 | 235 | 156 | 372 | 91.00 | 465 | 636 | 615 | 692 | 465 | 388 | 493 | 497 | 515 | 593 | 616 | 668 |
| Share Based Compensation | 14.2% | 61.00 | 54.00 | 55.00 | 57.00 | 58.00 | 61.00 | 60.00 | 65.00 | 68.00 | 67.00 | 59.00 | 55.00 | 54.00 | 56.00 | 52.00 | 52.00 | 43.00 | 37.00 | 38.00 | 42.00 | 51.00 |
| Cashflow From Investing | 96.5% | -70.90 | -2,040 | -1,958 | -1,974 | -500 | 1,453 | 1,276 | 1,190 | -301 | -227 | -187 | -166 | -779 | -901 | -596 | -535 | 64.00 | 105 | -126 | -14.70 | 27.00 |
| Cashflow From Financing | -143.7% | -184 | 423 | 422 | 406 | 413 | -187 | -178 | -322 | -932 | -289 | -181 | -11.20 | 490 | 108 | 2.00 | -1.00 | -31.50 | -450 | -571 | -921 | -918 |
| Dividend Payments | 1.1% | 146 | 144 | 142 | 139 | 134 | 131 | 130 | 129 | 127 | 126 | 124 | 122 | 120 | 117 | 112 | 110 | 107 | 104 | 105 | 101 | 98.00 |
| Buy Backs | - | - | - | - | - | - | - | - | - | - | - | 164 | 4.00 | - | - | - | - | - | 292 | 400 | 400 | 398 |
PRGO Income Statement
2023-07-01Condensed Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions | 3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jul. 01, 2023 | Jul. 02, 2022 | Jul. 01, 2023 | Jul. 02, 2022 | |
| Income Statement [Abstract] | ||||
| Net sales | $ 1,193.1 | $ 1,121.7 | $ 2,374.8 | $ 2,196.2 |
| Cost of sales | 765.1 | 749.6 | 1,532.9 | 1,486.3 |
| Gross profit | 428.0 | 372.1 | 841.9 | 709.9 |
| Operating expenses | ||||
| Distribution | 28.6 | 29.5 | 57.2 | 53.9 |
| Research and development | 32.2 | 31.5 | 63.3 | 60.8 |
| Selling | 171.1 | 150.8 | 339.0 | 286.4 |
| Administration | 132.6 | 157.8 | 267.6 | 280.1 |
| Restructuring | 6.7 | 9.5 | 10.2 | 13.1 |
| Other operating (income) expense, net | 0.0 | (0.1) | (0.8) | 0.8 |
| Total operating expenses | 371.2 | 379.0 | 736.5 | 695.1 |
| Operating income (loss) | 56.8 | (6.9) | 105.4 | 14.8 |
| Interest expense, net | 44.0 | 38.3 | 87.6 | 74.1 |
| Other (income) expense, net | (9.7) | 53.8 | (9.0) | 52.7 |
| Loss on extinguishment of debt | 0.0 | 9.3 | 0.0 | 9.3 |
| Income (loss) from continuing operations before income taxes | 22.5 | (108.3) | 26.8 | (121.3) |
| Income tax expense (benefit) | 13.6 | (43.4) | 19.0 | (55.1) |
| Income (loss) from continuing operations | 8.9 | (64.9) | 7.8 | (66.2) |
| Income (loss) from discontinued operations, net of tax | (0.5) | (0.2) | (2.4) | (1.4) |
| Net income (loss) | $ 8.4 | $ (65.1) | $ 5.4 | $ (67.6) |
| Basic | ||||
| Continuing operations (in dollars per share) | $ 0.07 | $ (0.48) | $ 0.06 | $ (0.49) |
| Discontinued operations (in dollars per share) | 0 | 0 | (0.02) | (0.01) |
| Basic earnings (loss) per share (in dollars per share) | 0.06 | (0.48) | 0.04 | (0.50) |
| Diluted | ||||
| Continuing operations (in dollars per share) | 0.06 | (0.48) | 0.06 | (0.49) |
| Discontinued operations (in dollars per share) | 0 | 0 | (0.02) | (0.01) |
| Diluted earnings (loss) per share (in dollars per share) | $ 0.06 | $ (0.48) | $ 0.04 | $ (0.50) |
| Weighted-average shares outstanding | ||||
| Basic (in shares) | 135.3 | 134.6 | 135.1 | 134.3 |
| Diluted (in shares) | 136.6 | 134.6 | 136.5 | 134.3 |
PRGO Balance Sheet
2023-07-01Condensed Consolidated Balance Sheets - USD ($) shares in Millions, $ in Millions | Jul. 01, 2023 | Dec. 31, 2022 |
|---|---|---|
| Assets | ||
| Cash and cash equivalents | $ 555.2 | $ 600.7 |
| Accounts receivable, net of allowance for credit losses of $8.1 and $6.8, respectively | 754.1 | 697.1 |
| Inventories | 1,167.5 | 1,150.3 |
| Prepaid expenses and other current assets | 296.2 | 271.8 |
| Total current assets | 2,773.0 | 2,719.9 |
| Property, plant and equipment, net | 918.3 | 926.3 |
| Operating lease assets | 206.9 | 217.1 |
| Goodwill and indefinite-lived intangible assets | 3,657.8 | 3,549.0 |
| Definite-lived intangible assets, net | 3,030.8 | 3,230.2 |
| Deferred income taxes | 6.3 | 7.1 |
| Other non-current assets | 371.6 | 367.7 |
| Total non-current assets | 8,191.7 | 8,297.4 |
| Total assets | 10,964.7 | 11,017.3 |
| Liabilities and Shareholders’ Equity | ||
| Accounts payable | 470.5 | 537.3 |
| Payroll and related taxes | 104.4 | 136.4 |
| Accrued customer programs | 174.3 | 139.1 |
| Other accrued liabilities | 261.7 | 250.2 |
| Accrued income taxes | 7.6 | 14.4 |
| Current indebtedness | 38.4 | 36.2 |
| Total current liabilities | 1,056.9 | 1,113.6 |
| Long-term debt, less current portion | 4,055.9 | 4,070.4 |
| Deferred income taxes | 344.6 | 368.2 |
| Other non-current liabilities | 658.7 | 623.0 |
| Total non-current liabilities | 5,059.2 | 5,061.6 |
| Total liabilities | 6,116.1 | 6,175.2 |
| Contingencies - Refer to Note 16 | ||
| Controlling interests: | ||
| Preferred shares, $0.0001 par value per share, 10 shares authorized | 0.0 | 0.0 |
| Ordinary shares, €0.001 par value per share, 10,000 shares authorized | 6,890.9 | 6,936.7 |
| Accumulated other comprehensive income | 19.9 | (27.0) |
| Retained earnings (accumulated deficit) | (2,062.2) | (2,067.6) |
| Total shareholders’ equity | 4,848.6 | 4,842.1 |
| Total liabilities and shareholders' equity | $ 10,964.7 | $ 11,017.3 |
| Supplemental Disclosures of Balance Sheet Information | ||
| Preferred shares, issued and outstanding (in shares) | 0.0 | 0.0 |
| Ordinary shares, issued and outstanding (in shares) | 135.4 | 134.7 |
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.